Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mai Luo Tong (脉络通) is a traditional Chinese medicine (TCM) or Chinese patent medicine primarily used for the treatment of cardiovascular and cerebrovascular diseases. It is generally indicated for conditions such as coronary heart disease with angina pectoris, hypertension, cerebrovascular accidents, and stroke-related symptoms like limb numbness and hemiplegia. Its therapeutic principles in TCM involve "unblocking meridians and collaterals, promoting qi circulation, and removing blood stasis." However, the exact composition of "Mai Luo Tong" can vary significantly between different manufacturers and formulations (e.g., tablets vs. capsules), with ingredients ranging from various herbs like Panax notoginseng, Salvia miltiorrhiza, and Angelica sinensis, to animal-derived components like Pheretima and artificial bezoar. It is classified as a pharmaceutical in China, evidenced by its "国药准字" (National Medical Product Administration approval number).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mai Luo Tong.